Author

Lenis Sosa

Institution: Houston Methodist

Observed institutions: Houston Methodist, Houston Methodist Sugar Land Hospital, The University of Texas Health Science Center at Houston

ORCID: 0000-0002-8220-2495

Observed ORCID: 0000-0002-8220-2495

OpenAlex ID: A5081381174

Design of a Prospective, Dose-Escalation Study Evaluating the Safety of Pioglitazone for Hematoma Resolution in Intracerebral Hemorrhage (SHRINC)

2012 · Nicole R. Gonzales, Jharna Shah, et al. · International Journal of Stroke · 83

Developing and Implementing a Narration of Care Framework to Teach Nurses When and How to Narrate Care

2025 · Courtenay R. Bruce, Natalie N. Zuniga-Georgy, et al. · Nursing Reports · 1

Preventing Drowsy Driving Crashes Among Night Shift Nurses: An Evaluation of Educational and Technological Interventions

2020 · Alec Smith, Anthony McDonald, et al. · Proceedings of the Human Factors and Ergonomics Society Annual Meeting · 1

Abstract T P227: The Safety of Pioglitazone for Hematoma Resolution in IntraCerebral Hemorrhage (SHRINC) Trial: Safety Results

2014 · Nicole R Gonzales, Navdeep Sangha, et al. · Stroke · 1

Implementation and Evaluation of the RECAP Framework: A Quality Improvement Initiative

2026 · Courtenay R. Bruce, Natalie N. Zuniga-Georgy, et al. · Nursing Reports

Abstract 3729: Delayed Hematoma Expansion Occurs After ICH: Observations from the Safety of Pioglitazone for Hematoma Resolution in INtraCerebral Hemorrhage (SHRINC) trial

2012 · Navdeep S Sangha, Farhaan Vahidy, et al. · Stroke

Works count: 6

Citation count: 86

H-index: 1

I10-index: 1